在治疗期间在瘤学中使用可穿戴传感器的经验:来自丹麦可行性研究项目的经验教训
Helle Pappot1,2, Emma Balch Steen-Olsen1, Cecilie Holländer-Mieritz1,3
1Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
Diagnostics (Basel, Switzerland)
|February 24, 2024
概括
可穿戴式传感器对瘤治疗有希望,但必须解决患者可用性挑战. 精简技术对于成功实施癌症治疗研究至关重要.
科学领域:
- 在瘤学瘤学.
- 数字健康数字健康
- 生物医学工程 生物医学工程
背景情况:
- 人口老龄化和癌症发病率增加给医疗保健系统带来了压力.
- 不断发展的癌症治疗需要创新的医疗保健工具.
- 可穿戴式传感器被探索为瘤学的潜在解决方案.
研究的目的:
- 描述丹麦在瘤学中使用可穿戴传感器的研究经验.
- 报告三项瘤可穿戴研究项目的研究结果.
主要方法:
- 三个计划的案例研究在癌症治疗期间可穿戴传感器的可行性.
- 专注于研究设计,患者群体,设备和结果.
- 两个实际的案例研究详细介绍了患者的纳入,数据收集和结果.
主要成果:
- 在计划中的三项研究中,只有两项完成.
- 患者在可穿戴传感器方面遇到了重大技术挑战.
- 通过有效的框架,可以进行大量的数据收集.
结论:
- 可穿戴传感器为临床瘤学提供了潜在的好处.
- 成功的研究和实施需要最小的患者努力.
- 优化面向患者的技术对于可穿戴传感器的采用至关重要.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...